Glutamate receptor mutations in psychiatric and neurodevelopmental disorders

Communicative and Integrative Biology

Volumn 7, Issue 2, 2014, Pages

  Soto, David ^a   Altafaj, Xavier ^a   Sindreu, Carlos ^b   Bayés, Àlex ^c,d  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Glutamate receptors; intellectual disability; neurodevelopmental disorders; psychiatric disorders

Indexed keywords

EID: 84901369071     PISSN: 19420889     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.2788     Document Type: Short Survey

References (50)

1. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nature reviews 2012; 13:537-51.
2. Posthuma D, Polderman TJC. What have we learned from recent twin studies about the etiology of neurodevelopmental disorders? Curr Opin Neurol 2013; 26:111-21; PMID:23426380; http://dx.doi. org/10.1097/WCO.0b013e32835f19c3
3. Gejman PV, Sanders AR, Kendler KS. Genetics of schizophrenia: new findings and challenges. Annu Rev Genomics Hum Genet 2011; 12:121-44; PMID:21639796; http://dx.doi.org/10.1146/ annurev-genom-082410-101459
4. Juli G, Juli M-R, Juli L. Involvement of genetic factors in bipolar disorders: current status. Psychiatr Danub 2012; 24(Suppl 1):S112-6; PMID:22945201
5. Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med 2010; 61:437-55; PMID:20059347; http://dx.doi. org/10.1146/annurev-med-100708-204735
6. Koboldt DC, Steinberg KM, Larson DE, Wilson RK, Mardis ER. The next-generation sequencing revolution and its impact on genomics. Cell 2013; 155:27-38; PMID:24074859; http://dx.doi. org/10.1016/j.cell.2013.09.006
7. Brose N, O'Connor V, Skehel P. Synaptopathy: dysfunction of synaptic function? Biochem Soc Trans 2010; 38:443-4; PMID:20298199; http://dx.doi. org/10.1042/BST0380443
8. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 2010; 62:405-96; PMID:20716669; http://dx.doi. org/10.1124/pr.109.002451
9. Nicoletti F, Bockaert J, Collingridge GL, Conn PJ, Ferraguti F, Schoepp DD, Wroblewski JT, Pin JP. Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 2011; 60:1017-41; PMID:21036182; http://dx.doi. org/10.1016/j.neuropharm.2010.10.022
10. Ramanathan S, Woodroffe A, Flodman PL, Mays LZ, Hanouni M, Modahl CB, Steinberg-Epstein R, Bocian ME, Spence MA, Smith M. A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamine and glycine neurotransmitter receptor sub-units (AMPA 2, GLRA3, GLRB) and neuropeptide receptors NPY1R, NPY5R. BMC Med Genet 2004; 5:10; PMID:15090072; http://dx.doi. org/10.1186/1471-2350-5-10
11. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V, Layet V, Rosier A, Briault S, Bonnet-Brilhault F, et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 2009; 66:947-56; PMID:19736351; http://dx.doi. org/10.1001/archgenpsychiatry.2009.80
12. Tzschach A, Menzel C, Erdogan F, Istifli ES, Rieger M, Ovens-Raeder A, Macke A, Ropers H-H, Ullmann R, Kalscheuer V. Characterization of an interstitial 4q32 deletion in a patient with mental retardation and a complex chromosome rearrangement. Am J Med Genet A 2010; 152A:1008-12; PMID:20358617; http://dx.doi.org/10.1002/ajmg.a.33343
13. Hackmann K, Matko S, Gerlach E-M, von der Hagen M, Klink B, Schrock E, Rump A, Di Donato N. Partial deletion of GLRB and GRIA2 in a patient with intellectual disability. Eur J Hum Genet 2013; 21:112-4; PMID:22669415; http://dx.doi. org/10.1038/ejhg.2012.97
14. Gécz J, Barnett S, Liu J, Hollway G, Donnelly A, Eyre H, Eshkevari HS, Baltazar R, Grunn A, Nagaraja R, et al. Characterization of the human glutamate receptor subunit 3 gene (GRIA3), a candidate for bipolar disorder and nonspecific X-linked mental retardation. Genomics 1999; 62:356-68; PMID:10644433; http://dx.doi.org/10.1006/geno.1999.6032
15. Jacquemont M-L, Sanlaville D, Redon R, Raoul O, Cormier-Daire V, Lyonnet S, Amiel J, Le Merrer M, Heron D, de Blois M-C, et al. Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet 2006; 43:843-9; PMID:16840569; http://dx.doi.org/10.1136/jmg.2006.043166
16. Philippe A, Malan V, Jacquemont M-L, Boddaert N, Bonnefont J-P, Odent S, Munnich A, Colleaux L, Cormier-Daire V. Xq25 duplications encompassing GRIA3 and STAG2 genes in two families convey recognizable X-linked intellectual disability with distinctive facial appearance. Am J Med Genet A 2013; 161A:1370-5; PMID:23637084; http://dx.doi. org/10.1002/ajmg.a.35307
17. Chiyonobu T, Hayashi S, Kobayashi K, Morimoto M, Miyanomae Y, Nishimura A, Nishimoto A, Ito C, Imoto I, Sugimoto T, et al. Partial tandem duplication of GRIA3 in a male with mental retardation. Am J Med Genet A 2007; 143A:1448-55; PMID:17568425; http://dx.doi.org/10.1002/ ajmg.a.31798
18. Bonnet C, Leheup B, Béri M, Philippe C, Grégoire M-J, Jonveaux P. Aberrant GRIA3 transcripts with multi-exon duplications in a family with X-linked mental retardation. Am J Med Genet A 2009; 149A:1280-9; PMID:19449417; http://dx.doi. org/10.1002/ajmg.a.32858
19. Bonnet C, Masurel-Paulet A, Khan AA, Béri-Dexheimer M, Callier P, Mugneret F, Philippe C, Thauvin-Robinet C, Faivre L, Jonveaux P. Exploring the potential role of disease-causing mutation in a gene desert: duplication of noncoding elements 5' of GRIA3 is associated with GRIA3 silencing and X-linked intellectual disability. Hum Mutat 2012; 33:355-8; PMID:22124977; http://dx.doi. org/10.1002/humu.21649
20. Wu Y, Arai AC, Rumbaugh G, Srivastava AK, Turner G, Hayashi T, Suzuki E, Jiang Y, Zhang L, Rodriguez J, et al. Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans. Proc Natl Acad Sci U S A 2007; 104:18163-8; PMID:17989220; http:// dx.doi.org/10.1073/pnas.0708699104
21. Meng Y, Zhang Y, Jia Z. Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3. Neuron 2003; 39:163-76; PMID:12848940; http://dx.doi.org/10.1016/ S0896-6273(03)00368-4
22. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361:31-9; PMID:8421494; http:// dx.doi.org/10.1038/361031a0
23. Straub C, Tomita S. The regulation of glutamate receptor trafficking and function by TARPs and other transmembrane auxiliary subunits. Curr Opin Neurobiol 2012; 22:488-95; PMID:21993243; http://dx.doi.org/10.1016/j.conb.2011.09.005
24. Hamdan FF, Gauthier J, Araki Y, Lin DT, Yoshizawa Y, Higashi K, Park AR, Spiegelman D, Dobrzeniecka S, Piton A, et al.; S2D Group. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet 2011; 88:306-16; PMID:21376300; http://dx.doi.org/10.1016/j. ajhg.2011.02.001
25. Floor K, Barøy T, Misceo D, Kanavin OJ, Fannemel M, Frengen E. A 1 Mb de novo deletion within 11q13.1q13.2 in a boy with mild intellectual disability and minor dysmorphic features. Eur J Med Genet 2012; 55:695-9; PMID:22986108; http://dx.doi. org/10.1016/j.ejmg.2012.08.002
26. Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 2013; 14:383-400; PMID:23686171; http://dx.doi. org/10.1038/nrn3504
27. Lemke JR, Hendrickx R, Geider K, Laube B, Schwake M, Harvey RJ, James VM, Pepler A, Steiner I, Hörtnagel K, et al. GRIN2B mutations in west syndrome and intellectual disability with focal epilepsy. Ann Neurol 2013; PMID:24272827; http:// dx.doi.org/10.1002/ana.24073
28. Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, Milh M, Kortüm F, Fritsch A, Pientka FK, et al. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 2010; 42:1021-6; PMID:20890276; http:// dx.doi.org/10.1038/ng.677
29. Dimassi S, Andrieux J, Labalme A, Lesca G, Cordier M-P, Boute O, Neut D, Edery P, Sanlaville D, Schluth-Bolard C. Interstitial 12p13.1 deletion involving GRIN2B in three patients with intellectual disability. Am J Med Genet A 2013; 161:2564-9; PMID:23918416
30. de Ligt J, Willemsen MH, van Bon BWM, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012; 367:1921-9; PMID:23033978; http://dx.doi.org/10.1056/ NEJMoa1206524
31. Tarabeux J, Kebir O, Gauthier J, Hamdan FF, Xiong L, Piton A, Spiegelman D, Henrion É, Millet B, Fathalli F, et al.; S2D team. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Transl Psychiatry 2011; 1:e55; PMID:22833210; http:// dx.doi.org/10.1038/tp.2011.52
32. O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, Carvill G, Kumar A, Lee C, Ankenman K, et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012; 338:1619-22; PMID:23160955; http://dx.doi.org/10.1126/ science.1227764
33. Reutlinger C, Helbig I, Gawelczyk B, Subero JIM, Tönnies H, Muhle H, Finsterwalder K, Vermeer S, Pfundt R, Sperner J, et al. Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region. Epilepsia 2010; 51:1870-3; PMID:20384727; http://dx.doi. org/10.1111/j.1528-1167.2010.02555.x
34. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, Karakoc E, Mackenzie AP, Ng SB, Baker C, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011; 43:585-9; PMID:21572417; http://dx.doi.org/10.1038/ng.835
35. Gai X, Xie HM, Perin JC, Takahashi N, Murphy K, Wenocur AS, D'arcy M, O'Hara RJ, Goldmuntz E, Grice DE, et al. Rare structural variation of synapse and neurotransmission genes in autism. Mol Psychiatry 2012; 17:402-11; PMID:21358714; http:// dx.doi.org/10.1038/mp.2011.10
36. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008; 40:827-34; PMID:18583979; http://dx.doi.org/10.1038/ng.171
37. Contractor A, Mulle C, Swanson GT. Kainate receptors coming of age: milestones of two decades of research. Trends Neurosci 2011; 34:154-63; PMID:21256604; http://dx.doi.org/10.1016/j. tins.2010.12.002
38. Poot M, Eleveld MJ, van 't Slot R, Ploos van Amstel HK, Hochstenbach R. Recurrent copy number changes in mentally retarded children harbour genes involved in cellular localization and the glutamate receptor complex. Eur J Hum Genet 2010; 18:39-46; PMID:19623214; http://dx.doi.org/10.1038/ ejhg.2009.120
39. Motazacker MM, Rost BR, Hucho T, Garshasbi M, Kahrizi K, Ullmann R, Abedini SS, Nieh SE, Amini SH, Goswami C, et al. A defect in the ionotropic glutamate receptor 6 gene (GRIK2) is associated with autosomal recessive mental retardation. Am J Hum Genet 2007; 81:792-8; PMID:17847003; http:// dx.doi.org/10.1086/521275
40. Pickard BS, Knight HM, Hamilton RS, Soares DC, Walker R, Boyd JKF, Machell J, Maclean A, McGhee KA, Condie A, et al. A common variant in the 3'UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorder. Proc Natl Acad Sci U S A 2008; 105:14940-5; PMID:18824690; http://dx.doi.org/10.1073/ pnas.0800643105
41. Whalley HC, Pickard BS, McIntosh AM, Zuliani R, Johnstone EC, Blackwood DHR, Lawrie SM, Muir WJ, Hall J. A GRIK4 variant conferring protection against bipolar disorder modulates hippocampal function. Mol Psychiatry 2009; 14:467-8; PMID:19384319; http://dx.doi.org/10.1038/ mp.2009.7
42. Frank RAW, McRae AF, Pocklington AJ, van de Lagemaat LN, Navarro P, Croning MDR, Komiyama NH, Bradley SJ, Challiss RAJ, Armstrong JD, et al. Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder. PLoS One 2011; 6:e19011; PMID:21559497; http://dx.doi.org/10.1371/journal. pone.0019011
43. Ayoub MA, Angelicheva D, Vile D, Chandler D, Morar B, Cavanaugh JA, Visscher PM, Jablensky A, Pfleger KDG, Kalaydjieva L. Deleterious GRM1 mutations in schizophrenia. PLoS One 2012; 7:e32849; PMID:22448230; http://dx.doi. org/10.1371/journal.pone.0032849
44. Kandaswamy R, McQuillin A, Sharp SI, Fiorentino A, Anjorin A, Blizard RA, Curtis D, Gurling HMD. Genetic association, mutation screening, and functional analysis of a Kozak sequence variant in the metabotropic glutamate receptor 3 gene in bipolar disorder. JAMA Psychiatry 2013; 70:591-8; PMID:23575746; http://dx.doi.org/10.1001/ jamapsychiatry.2013.38
45. Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, Sleiman PMA, Zhang H, Kim CE, Robison R, et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet 2012; 44:78-84; PMID:22138692; http://dx.doi.org/10.1038/ng.1013
46. Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A 2004; 101:12604-9; PMID:15310849; http://dx.doi. org/10.1073/pnas.0405077101
47. Krueger DD, Bear MF. Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome. Annu Rev Med 2010; PMID:21090964
48. Kelleher RJ 3rd, Bear MF. The autistic neuron: troubled translation? Cell 2008; 135:401-6; PMID:18984149; http://dx.doi.org/10.1016/j.cell.2008.10.017
49. Sheng M, Cummings J, Roldan LA, Jan YN, Jan LY. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 1994; 368:144-7; PMID:8139656; http:// dx.doi.org/10.1038/368144a0
50. Zhu JJ, Esteban JA, Hayashi Y, Malinow R. Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity. Nat Neurosci 2000; 3:1098-106; PMID:11036266; http://dx.doi.org/10.1038/80614